ONYX-015: Began Phase I testing

Onyx Pharmaceuticals Inc. (ONXX), Richmond, Calif. Product: ONYX-015 Business: Cancer Therapeutic category: Cell proliferation Target: Tumor cells lacking the p53 tumor suppressor protein Description:...